Other

Increase (Decrease) in Inventories

Vertex Pharmaceuticals Increase (Decrease) in Inventories increased by 26.2% to $97.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 41.5%, from $167.10M to $97.70M. Over 4 years (FY 2021 to FY 2025), Increase (Decrease) in Inventories shows an upward trend with a 54.2% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026

How to read this metric

An increase may signal expected demand growth or supply chain bottlenecks, while a decrease might indicate strong sales or inventory optimization efforts.

Detailed definition

Represents the net change in the value of raw materials, work-in-progress, and finished goods held by the company. This...

Peer comparison

Standard metric for manufacturing and industrial firms; essential for evaluating inventory turnover and operational health.

Metric ID: other_increase_decrease_in_inventories

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$24.70M$18.30M$27.00M-$2.00M$33.30M$26.80M$78.30M$80.73M$80.73M$80.73M$80.73M$80.10M$107.20M$182.50M$147.50M$167.10M$148.60M$131.10M$77.40M$97.70M
QoQ Change-25.9%+47.5%-107.4%>999%-19.5%+192.2%+3.1%+0.0%+0.0%+0.0%-0.8%+33.8%+70.2%-19.2%+13.3%-11.1%-11.8%-41.0%+26.2%
YoY Change+34.8%+46.4%+190.0%>999%+142.4%+201.2%+3.1%-0.8%+32.8%+126.1%+82.7%+108.6%+38.6%-28.2%-47.5%-41.5%
Range-$2.00M$182.50M
CAGR+33.6%
Avg YoY Growth+314.1%
Median YoY Growth+42.5%

Frequently Asked Questions

What is Vertex Pharmaceuticals's increase (decrease) in inventories?
Vertex Pharmaceuticals (VRTX) reported increase (decrease) in inventories of $97.70M in Q1 2026.
How has Vertex Pharmaceuticals's increase (decrease) in inventories changed year-over-year?
Vertex Pharmaceuticals's increase (decrease) in inventories decreased by 41.5% year-over-year, from $167.10M to $97.70M.
What is the long-term trend for Vertex Pharmaceuticals's increase (decrease) in inventories?
Over 4 years (2021 to 2025), Vertex Pharmaceuticals's increase (decrease) in inventories has grown at a 54.2% compound annual growth rate (CAGR), from $92.80M to $524.20M.
What does increase (decrease) in inventories mean?
The change in the total value of products and materials the company has in stock.